SSGJ-613

DRUG2 trials

Sponsors

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Conditions

Arthritis, GoutyPeriodic Fever SyndromeSystemic Juvenile Idiopathic Arthritis

Phase 1

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Periodic Fever Syndrome, Systemic Juvenile Idiopathic Arthritis

Start: 2021-08-13End: 2022-09-30Target: 34Updated: 2021-08-30

The MAD Study of SSGJ-613 in Healthy Subjects

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Arthritis, Gouty

Start: 2023-08-10End: 2024-03-10Target: 36Updated: 2023-08-01